Abiraterone in metastatic prostate cancer [5]

Ganessan Kichenadasse; Christos Karapetis

doi:10.1056/NEJMc1301594

Abiraterone in metastatic prostate cancer [5]

Ganessan Kichenadasse, Christos Karapetis

Research output: Contribution to journal › Letter › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	1457-1459
Number of pages	3
Journal	New England Journal of Medicine
Volume	368
Issue number	15
DOIs	https://doi.org/10.1056/NEJMc1301594
Publication status	Published - 11 Apr 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1056/NEJMc1301594Licence: In Copyright

Cite this

@article{a33a510bc45a47959910473fd514adad,

title = "Abiraterone in metastatic prostate cancer [5]",

author = "Ganessan Kichenadasse and Christos Karapetis",

year = "2013",

month = apr,

day = "11",

doi = "10.1056/NEJMc1301594",

language = "English",

volume = "368",

pages = "1457--1459",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "15",

}

TY - JOUR

T1 - Abiraterone in metastatic prostate cancer [5]

AU - Kichenadasse, Ganessan

AU - Karapetis, Christos

PY - 2013/4/11

Y1 - 2013/4/11

UR - http://www.scopus.com/inward/record.url?scp=84875949371&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1301594

DO - 10.1056/NEJMc1301594

M3 - Letter

SN - 0028-4793

VL - 368

SP - 1457

EP - 1459

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 15

ER -

Abiraterone in metastatic prostate cancer [5]

UN SDGs

Access to Document

Other files and links

Cite this